HDAC9 and glioblastoma: Furthermore, the therapeutic potential of HDAC SIRT1 and HDACSIRT-2 in GBM was studied in Hs683 and U373 cells, revealing thatSIRT1 was highly expressed in Hs683 cells, whereas SIRT-2 was expressedin U373 cells.